Interface Biologics is a developer of transformative biomedical polymer technology solutions that improve the safety and effectiveness of medical devices. Its primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.